<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Posts on Mycobacterial Infection Research Unit</title>
    <link>https://miru-ffm.org/news/</link>
    <description>Recent content in Posts on Mycobacterial Infection Research Unit</description>
    <generator>Source Themes academia (https://sourcethemes.com/academic/)</generator>
    <language>en-us</language>
    <copyright>Copyright &amp;copy; {year}</copyright>
    <lastBuildDate>Mon, 18 Nov 2024 00:00:00 +0000</lastBuildDate>
    
	    <atom:link href="https://miru-ffm.org/news/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>New publication in Infection</title>
      <link>https://miru-ffm.org/news/post6/</link>
      <pubDate>Mon, 18 Nov 2024 00:00:00 +0000</pubDate>
      
      <guid>https://miru-ffm.org/news/post6/</guid>
      <description>&lt;img src=&#34;figure_2.jpg&#34;&gt;
&lt;br&gt;
Drug-sensitive TB (DS-TB) is treated with isoniazid, rifampicin, ethambutol, and pyrazinamide. Factors like fast-metabolizing enzymes, malabsorption, and drug interactions can influence serum drug levels. Current TB treatment guidelines recommend weight-adapted dosing without considering sex differences. 
&lt;br&gt;&lt;br&gt;
In this study, we examine drug levels of isoniazid and rifampicin in TB patients treated between 2019 and 2023 at our center focusing on sex-specific aspects.
&lt;br&gt;&lt;br&gt;
Interestingly, rifampicin levels were significantly lower in men compared to women, despite weight-adjusted dosing. 
&lt;br&gt;&lt;br&gt;
You can find the paper here, at 
&lt;a href=&#34;https://miru-ffm.org/publication/infection_2024&#34;&gt;miru-ffm.org&lt;/a&gt;, &lt;a href=&#34;https://link.springer.com/article/10.1007/s15010-024-02424-5&#34;&gt; the journal&#39;s homepage&lt;/a&gt;, or at &lt;a href=&#34;https://pubmed.ncbi.nlm.nih.gov/39531129/&#34;&gt;PubMed&lt;/a&gt;.
</description>
    </item>
    
    <item>
      <title>New publication in Genome Medicine</title>
      <link>https://miru-ffm.org/news/post5/</link>
      <pubDate>Mon, 15 Jul 2024 00:00:00 +0000</pubDate>
      
      <guid>https://miru-ffm.org/news/post5/</guid>
      <description>&lt;img src=&#34;figure2.png&#34;&gt;
&lt;br&gt;
The &lt;i&gt;Mycobacterium avium&lt;/i&gt; complex comprises the most frequent non-tuberculous mycobacteria in Europe. &lt;i&gt;M. chimaera&lt;/i&gt;, &lt;i&gt;M. intracellulare&lt;/i&gt;, and &lt;i&gt;M. avium&lt;/i&gt; are clinically most relevant.  
&lt;br&gt;&lt;br&gt;
In this new publication, we present a clinico-genomic dataset of more than 400 patients from Germany and Continental Europe. 
&lt;br&gt;&lt;br&gt;
You can find the paper here, at 
&lt;a href=&#34;https://miru-ffm.org/publication/gm_2024&#34;&gt;miru-ffm.org&lt;/a&gt;, &lt;a href=&#34;https://rdcu.be/dNhDe&#34;&gt; the journal&#39;s homepage&lt;/a&gt;, or at &lt;a href=&#34;https://pubmed.ncbi.nlm.nih.gov/38982539/&#34;&gt;PubMed&lt;/a&gt;.
</description>
    </item>
    
    <item>
      <title>New publication in the Journal of Infection</title>
      <link>https://miru-ffm.org/news/post4/</link>
      <pubDate>Thu, 27 Jun 2024 00:00:00 +0000</pubDate>
      
      <guid>https://miru-ffm.org/news/post4/</guid>
      <description>&lt;img src=&#34;gr1.jpg&#34;&gt;
&lt;br&gt;
&lt;i&gt;Mycobacterium malmoense&lt;/i&gt; is a rare cause of NTM pulmonary disease. In this systemativ review and meta-analysis, we summarize the available clinical data of &lt;i&gt;M. malmoense&lt;/i&gt; infection from more than 800 patients. The pathogen is shown to be of high clinical relevance and macrolide or rifamycin containing regimens might improve survival in affected patients.  
&lt;br&gt;&lt;br&gt;
We are very happy to see the result of this Danish-German collaboration finally published in the Journal of Infection.
&lt;br&gt;&lt;br&gt;
You can find the paper here, at 
&lt;a href=&#34;https://miru-ffm.org/publication/yjinf_2024&#34;&gt;miru-ffm.org&lt;/a&gt;, &lt;a href=&#34;https://www.journalofinfection.com/article/S0163-4453(24)00137-3/fulltext&#34;&gt; the journal&#39;s homepage&lt;/a&gt;, or at &lt;a href=&#34;https://pubmed.ncbi.nlm.nih.gov/38906266/&#34;&gt;PubMed&lt;/a&gt;.
</description>
    </item>
    
    <item>
      <title>New publication in Scientific Reports</title>
      <link>https://miru-ffm.org/news/post3/</link>
      <pubDate>Mon, 10 Jun 2024 00:00:00 +0000</pubDate>
      
      <guid>https://miru-ffm.org/news/post3/</guid>
      <description>&lt;img src=&#34;figure_2.png&#34;&gt;
&lt;br&gt;
In collaboration with the Department of Radiology at University Hospital Frankfurt, we investigated the radiological features of patients infected or colonised with slow-growing non-tuberculous mycobacteria. We applied a score, originally described for MAC pulmonary disease, to other SGM-species. We are very happy that the manuscript has been accepted for publication in &lt;i&gt;Scientific Reports&lt;/i&gt;, now.
&lt;br&gt;
&lt;br&gt;
You can find the paper here, at 
&lt;a href=&#34;https://miru-ffm.org/publication/scirep_2024&#34;&gt;miru-ffm.org&lt;/a&gt;, &lt;a href=&#34;https://www.nature.com/articles/s41598-024-64029-0&#34;&gt; the journal&#39;s homepage&lt;/a&gt;, or at &lt;a href=&#34;https://pubmed.ncbi.nlm.nih.gov/38858499/&#34;&gt;PubMed&lt;/a&gt;.
</description>
    </item>
    
    <item>
      <title>Successful clinical tuberculosis symposium taken place</title>
      <link>https://miru-ffm.org/news/post2/</link>
      <pubDate>Tue, 14 May 2024 00:00:00 +0000</pubDate>
      
      <guid>https://miru-ffm.org/news/post2/</guid>
      <description>&lt;img src=&#34;flyer_program.png&#34;&gt;
&lt;br&gt;
The second Clinical Tuberculosis Symposium of the DGI section &#34;Mycobacterioses&#34; has taken place in Frankfurt. This joint event was organised by DGI, DZIF, DGP, DGPI, and DZK. More than 70 persons participated and learned about the newest evolutions in tuberculosis care and research. We are very happy to have had the opportunity to host this event at University Hospital Frankfurt, Department of Infectious Diseases.
&lt;br&gt;
&lt;br&gt;
Third round will take place in &lt;a href=&#34;https://denkglobaldx.org/&#34;&gt;Heidelberg&lt;/a&gt;.
&lt;br&gt;
See you there!
</description>
    </item>
    
    <item>
      <title>Mycobacterial Infection Research Unit (MIRU) online</title>
      <link>https://miru-ffm.org/news/post1/</link>
      <pubDate>Mon, 13 May 2024 00:00:00 +0000</pubDate>
      
      <guid>https://miru-ffm.org/news/post1/</guid>
      <description>&lt;h2 id=&#34;welcome-to-the-miru&#34;&gt;Welcome to the MIRU&lt;/h2&gt;
&lt;img src=&#34;featured.png&#34;&gt;
&lt;br&gt;
We are happy to finally have launched our website. &lt;b&gt;miru.org&lt;/b&gt; is the homepage of our research group based at the University Hospital Frankfurt and in close cooperation with other collaborating centers. We investigate mycobacterial infections including tuberculosis and non-tuberculous mycobacterial infection with a variety of mehtods. On this site we will share ongoing projects, latest news and other relevant information.
&lt;br&gt;
&lt;br&gt;
Don&#39;t hesitate to get in touch!
</description>
    </item>
    
  </channel>
</rss>
